Jiao Jingjing, Zhang Xuchen
Department of Pathology and Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.
J Clin Transl Pathol. 2022 Sep;2(3):100-107. doi: 10.14218/jctp.2022.00016. Epub 2022 Aug 31.
Post-infantile giant cell hepatitis (PIGCH) is a rare disease entity in adults with a multifactorial etiology and widely variable clinical courses and outcomes. The factors associated with the worse outcomes of this disease entity are still unclear. We identified 68 PIGCH patients by searching PubMed and performed meta-analysis. Among the 68 patients, 32% of the cases were associated with autoimmune disorders, followed by 21% associated with viral infections, 10% with medication, and 7% with malignancy. Twenty-four percent of the patients had more than one etiological factor, and 6% had other uncommon etiologies or an etiology that could not be identified. At the time of this report, 17 patients had died of the disease (poor outcome), and 51 patients remained alive with the disease (good outcome). Compared to the patients with a good outcome, the patients with a poor outcome were characterized by older age, lower levels of platelets and albumin, higher level of total bilirubin, and a diffuse distribution pattern of giant cells in the liver. There were no differences in gender distribution, aminotransferase, alkaline phosphatase, gamma-glutamyl transferase, etiological distribution, or other histological features, including interface hepatitis, necrosis, lobular inflammation, portal inflammation, cholestasis, or fibrosis. Further studies would be needed to better understand the disease mechanisms and unmask any additional etiological factors and targeted therapies.
婴儿期后巨细胞肝炎(PIGCH)是一种在成人中罕见的疾病实体,病因多因素,临床病程和结局差异很大。与该疾病实体较差结局相关的因素仍不清楚。我们通过检索PubMed确定了68例PIGCH患者并进行了荟萃分析。在这68例患者中,32%的病例与自身免疫性疾病相关,其次是21%与病毒感染相关,10%与药物相关,7%与恶性肿瘤相关。24%的患者有不止一种病因,6%有其他不常见病因或无法确定的病因。在本报告发布时,17例患者死于该疾病(结局差),51例患者仍存活(结局好)。与结局好的患者相比,结局差的患者具有年龄较大、血小板和白蛋白水平较低、总胆红素水平较高以及肝脏中巨细胞弥漫分布模式的特点。在性别分布、氨基转移酶、碱性磷酸酶、γ-谷氨酰转移酶、病因分布或其他组织学特征(包括界面性肝炎、坏死、小叶炎症、门管区炎症、胆汁淤积或纤维化)方面没有差异。需要进一步研究以更好地了解疾病机制并揭示任何其他病因因素和靶向治疗方法。